Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Buxhofer-Ausch, Veronika; | Ausch, Christoph; | Zeillinger, Robert | Oberkanins, Christian | Dandachi, Nadia | Reiner-Concin, Angelika | Kriegshäuser, Gernot;
Affiliations: Second Department of Medicine, Donauspital, Vienna, Austria | Ludwig Boltzmann Research Society – Cluster Translational Oncology, Vienna, Austria | Department of Surgery, Donauspital, Vienna, Austria | ViennaLab Diagnostics GmbH, Vienna, Austria | Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria | Department of Pathology, Donauspital, Vienna, Austria
Note: [] Corresponding author: Gernot Kriegshäuser, ViennaLab Diagnostics GmbH, Vienna, Austria. Tel.: +43 1 8120 15610; Fax: +43 1 8120 15619; E-mail: kriegshauser@viennalab.co.at
Abstract: We report the performance evaluation of a non-quantitative reverse-hybridization assay (KRAS-BRAF StripAssay) designed for the simultaneous detection of 10 mutations in codons 12 and 13 of the KRAS gene and BRAF mutation V600E. Dilution experiments using DNA from tumor cell lines or from formalin-fixed paraffin-embedded (FFPE) colorectal cancer (CRC) tissue were performed to assess assay sensitivity. Using 50 ng of total DNA (mutant and wild-type), the KRAS-BRAF StripAssay demonstrated a detection limit of 1% mutant sequence in a background of wild-type DNA. With respect to BRAF V600E, the KRAS-BRAF StripAssay was evaluated using 60 FFPE CRC samples previously analyzed by high resolution melting (HRM). Test strip hybridization identified 2/60 (3%) samples to carry the BRAF V600E mutation, and results were in agreement with those obtained by HRM analysis. This work demonstrates the KRAS-BRAF StripAssay to be a robust and sensitive method for the detection of common KRAS/BRAF mutations in genomic DNA isolated from FFPE tissue samples.
Keywords: KRAS, BRAF, mutation detection, reverse-hybridization, high-resolution melting
DOI: 10.3233/DMA-120960
Journal: Disease Markers, vol. 34, no. 3, pp. 171-177, 2013
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl